Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Iscience
|
July 5, 2020
Triboelectric Nanogenerator versus Piezoelectric Generator at Low Frequency (<4 Hz): A Quantitative Comparison
Abdelsalam Ahmed, Islam Hassan, Ahmed S Helal, et al.
Nanotechnology
|
April 12, 2017
Design guidelines of triboelectric nanogenerator for water wave energy harvesters
Abdelsalam Ahmed, Islam Hassan, Tao Jiang, et al.
Medical Physics
|
May 26, 2018
Comparison of functional localization accuracy with different co-registration strategies in presurgical fMRI for brain tumor patients
Mu-Lan Jen, Islam Hassan, Ping Hou, et al.
Seizure
|
September 19, 2018
Experience of psychogenic nonepileptic seizures in the Canadian league against epilepsy: A survey describing current practices by neurologists and epileptologists
Alexandra Carter, Alyssa Denton, Lady D Ladino, et al.
Nano Energy
|
September 21, 2020
All printable snow-based triboelectric nanogenerator
Abdelsalam Ahmed, Islam Hassan, Islam M Mosa, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 25, 2019
Integrated Triboelectric Nanogenerators in the Era of the Internet of Things
Abdelsalam Ahmed, Islam Hassan, Maher F El-Kady, et al.
Scientific Reports
|
December 8, 2017
Self-adaptive Bioinspired Hummingbird-wing Stimulated Triboelectric Nanogenerators
Abdelsalam Ahmed, Islam Hassan, Peiyi Song, et al.
Scientific Reports
|
May 7, 2016
Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity
Islam Hassan, Aikaterini Kotrotsou, Ali Shojaee Bakhtiari, et al.
Neuro-Oncology Advances
|
August 29, 2022
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
Nicholas S Cho, Akifumi Hagiwara, Blaine S C Eldred, et al.
Neuro-Oncology
|
November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib
Benjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Iscience
|
July 5, 2020
Triboelectric Nanogenerator versus Piezoelectric Generator at Low Frequency (<4 Hz): A Quantitative Comparison
Abdelsalam Ahmed, Islam Hassan, Ahmed S Helal, et al.
Nanotechnology
|
April 12, 2017
Design guidelines of triboelectric nanogenerator for water wave energy harvesters
Abdelsalam Ahmed, Islam Hassan, Tao Jiang, et al.
Medical Physics
|
May 26, 2018
Comparison of functional localization accuracy with different co-registration strategies in presurgical fMRI for brain tumor patients
Mu-Lan Jen, Islam Hassan, Ping Hou, et al.
Seizure
|
September 19, 2018
Experience of psychogenic nonepileptic seizures in the Canadian league against epilepsy: A survey describing current practices by neurologists and epileptologists
Alexandra Carter, Alyssa Denton, Lady D Ladino, et al.
Nano Energy
|
September 21, 2020
All printable snow-based triboelectric nanogenerator
Abdelsalam Ahmed, Islam Hassan, Islam M Mosa, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 25, 2019
Integrated Triboelectric Nanogenerators in the Era of the Internet of Things
Abdelsalam Ahmed, Islam Hassan, Maher F El-Kady, et al.
Scientific Reports
|
December 8, 2017
Self-adaptive Bioinspired Hummingbird-wing Stimulated Triboelectric Nanogenerators
Abdelsalam Ahmed, Islam Hassan, Peiyi Song, et al.
Scientific Reports
|
May 7, 2016
Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity
Islam Hassan, Aikaterini Kotrotsou, Ali Shojaee Bakhtiari, et al.
Neuro-Oncology Advances
|
August 29, 2022
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
Nicholas S Cho, Akifumi Hagiwara, Blaine S C Eldred, et al.
Neuro-Oncology
|
November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib
Benjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.
Page
of 3